{
    "title": "Lilly profit plunges as cheaper generics take toll",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2804759/Lilly-profit-plunges-cheaper-generics-toll.html",
    "date": "2014-10-23",
    "keywords": [
        "percent",
        "year",
        "share",
        "profit",
        "drug",
        "quarter",
        "growth",
        "october",
        "ransdell",
        "research",
        "analyst",
        "treatment",
        "company",
        "form",
        "insulin",
        "return",
        "toll",
        "gmt",
        "email",
        "piersonoct",
        "co",
        "competition",
        "drugmaker",
        "thursday",
        "average",
        "thomson",
        "jeffrey",
        "holford",
        "development",
        "statesthe",
        "pain",
        "december",
        "cymbalta",
        "osteoporosis",
        "evista",
        "midday",
        "trading",
        "cancer",
        "arthritis",
        "cholesterol",
        "psoriasisus",
        "jardiance",
        "empagliflozin",
        "trulicity",
        "dulaglutide",
        "type",
        "approval",
        "sas",
        "glargine",
        "lantus",
        "basaglar",
        "number",
        "market",
        "margin",
        "improvement",
        "damien",
        "conover",
        "inflection",
        "pointconover",
        "industry",
        "premium",
        "impotence",
        "cialis",
        "humalog",
        "insulinthe",
        "companys",
        "health",
        "unit",
        "decline",
        "reporting",
        "pierson",
        "von",
        "ahn",
        "chizu",
        "nomiyama"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}